The Royal Childrens Hospital

Melbourne, Victoria 3052

1 studies enrolling now · 7 studies all time

What they study most

Angelman Syndrome, Brain Injuries, Cystic Fibrosis, Heart Failure, INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Ornithine Carbamoyltransferase Deficiency (Disorder), Ornithine Transcarbamylase Deficiency, Ornithine Transcarbamylase Deficiency Disease, Recurrent Wheezing, Respiratory Failure, Rhabdoid Tumors

Studies at this site

• An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency — Recruiting now
• Long-term Extension of GTX-102 in Angelman Syndrome — Enrolling by invitation
• A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing — Running, not enrolling
• EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma — Completed
• Heart And Lung Failure - Pediatric INsulin Titration Trial — Completed
• MRI Markers of Outcome After Severe Pediatric TBI — Completed
• Viral Pathogenesis of Early Cystic Fibrosis Lung Disease — Completed